OTCPicks.com Daily Market Movers Digest Midday Report for Friday, September 14th

OTCPicks Publisher Newsletter

OTCPicks.com Daily Market Movers Digest Midday Report for Friday, September 14th FLTT, DARA, NEXS, BIOF, MHYS, ONTC Our Stocks to Watch today include Flint Telecom Group Inc. (OTCBB: FLTT), DARA BioSciences Inc. (Nasdaq: DARA), Nexxus Lighting Inc. (Nasdaq: NEXS), BioFuel Energy Corp. (Nasdaq: BIOF), Mass Hysteria Entertainment Company Inc. (OTC: MHYS) and Onteco Corp. (OTC: ONTC).

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N41&L1&F=T to register for our Daily Market Movers Digest Newsletter and Email Stock Watch Alerts.

FLINT TELECOM GROUP INCORPORATED (OTCBB: FLTT) “Up 100.00% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N41&L71&F=T Flint Telecom Group Inc. is an international Telecoms Technology Organization with a portfolio of companies that deliver VoIP and wireless communications and prepaid financial products and services globally.

Headquartered in Overland Park, Kansas with offices throughout the US, India and Ireland, Flint Telecom Group is a fully reporting company trading on the OTC Bulletin Board (OTCBB) under the ticker symbol: FLTT.OB. Flint Telecom ranked number 72 in the 2010 Deloitte Technology Fast 500, Deloitte`s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Flint Telecom was founded by a team of telecom and technology experts with a proven track in building and maintaining international technology companies.

FLTT News:

No recent news for Flint Telecom Group, Inc. (OTCBB: FLTT).

DARA BIOSCIENCES INCORPORATED (NASDAQ: DARA) “Up 16.08% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N41&L9&F=T DARA is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. DARA increased its focus in oncology through its January 2012 acquisition of Oncogenerix, Inc., which holds the exclusive U.S. marketing rights to Soltamox, a novel oral liquid formulation of tamoxifen citrate which is widely used in the treatment and prevention of breast cancer. Soltamox is the only FDA approved oral liquid version of tamoxifen citrate and fulfills a vital clinical need for patients who cannot tolerate existing solid tablet formulations of this drug. DARA plans to begin marketing Soltamox in the U.S. later this year. Additionally, in June 2012 DARA launched its first product, Bionect, a topical treatment for skin irritation and burns associated with radiation therapy.

DARA News:

September 13 – Helsinn Grants to DARA Exclusive U.S. Commercial Rights to Gelclair, an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis Gelclair Strengthens DARAs Growing Portfolio of In-licensed Oncology and Oncology Supportive Care Products The Helsinn Group of Switzerland announced today that it has entered into an exclusive agreement with DARA BioSciences, Inc. (Nasdaq: DARA) for U.S.

commercial rights to Gelclair. Gelclair is an FDA-cleared product indicated for the treatment of oral mucositis. DARA plans to launch Gelclair in the first quarter of 2013.

Oral mucositis is a painful inflammation and ulceration of the surface of the mouth and throat, which can result from a variety of cancer treatments.

Gelclair is a topical gel used to coat and protect the oral cavity to reduce pain.

David J. Drutz, MD, DARA`s chief executive officer, stated, “The exclusive agreement with Helsinn for rights to commercialize Gelclair is a significant milestone that provides us with an important commercial product in an area of significant medical need. Hundreds of thousands of cancer patients suffer from oral mucositis each year. Dr. Drutz continued, Helsinn offers DARA a respected partner with extensive experience in the oncology supportive care market. Our joint undertaking also provides the potential opportunity for a meaningful and long-term commercial and developmental relationship between our two companies.

Helsinn CEO, Riccardo Braglia, said We are excited to have a partner, in DARA, who has the same commitment to the oncology supportive care market as we do. We believe DARA will support Gelclair with the programs necessary to ensure health care providers and patients have this valuable product available as part of their treatment regimen. The shared vision of both Helsinn and DARA provides a sound foundation for a successful, long-term collaboration.

ABOUT ORAL MUCOSITIS The American Cancer Society estimates that approximately 400,000 patients annually will experience oral mucositis as a result of cancer treatment.

The National Cancer Institute estimates that almost 100 percent of patients receiving radiation therapy for head and neck cancers experience oral mucositis, as do 80 percent of patients undergoing hematopoietic stem cell transplantation and 40 percent of patients receiving standard-dose chemotherapy.

The consequences of mucositis are far-reaching and include pain, difficulty swallowing, interruption of chemotherapy or radiation treatment, administration of narcotics, hospitalization and, in the most severe cases, reliance on parenteral nutrition.

Gelclair provides a synergistic fit within DARAs oncology supportive care portfolio. DARAs three FDA-approved/cleared products (Bionect, Soltamox and Gelclair), and a fourth, gemcitabine, due for ANDA submission by end of 2012, are focused on the needs of oncology patients.

DARA licensed all four agents this year as part of its strategy to build a portfolio of niche opportunity products for the oncology and oncology supportive care markets.

DARA increased its focus in oncology treatment and supportive care products through its January 2012 acquisition of Oncogenerix, Inc. In June 2012, DARA launched its first product, Bionect, a topical treatment for skin irritation and burns associated with radiation therapy. It is preparing for the launch of Soltamox, the first and only FDA-approved oral liquid formulation of tamoxifen citrate, a widely used therapy for the prevention and treatment of breast cancer. Its product portfolio also includes KRN5500, a novel therapy under development for the treatment of neuropathic pain in patients with cancer, a condition with no current adequate therapy.

ABOUT HELSINN GROUP Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United States. Helsinns business model is focused on the licensing of pharmaceuticals, medical devices and nutritional supplement products in therapeutic niche areas. Helsinn is an important player in cancer supportive care. Helsinn Group in-licenses early-to-late stage new chemical entities, completes their development through the performance of pre-clinical /clinical studies and Chemistry, Manufacturing, and Control (CMC) development, and files and attains their market approvals worldwide.

Helsinns products are out-licensed to its network of local marketing and commercial partners, selected for their deep in-market knowledge and know-how whom Helsinn assists and supports by providing a full range of product and scientific management services, including commercial, regulatory financial, legal, and medical marketing advice. The active pharmaceutical ingredients and the finished products are manufactured according to the highest quality, safety, and environmental standards at Helsinns GMP facilities in Switzerland and Ireland and supplied worldwide to its customers.

NEXXUS LIGHTING INCORPORATED (NASDAQ: NEXS) “Up 18.74% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N41&L29&F=T Nexxus Lighting, Inc. engages in the design, manufacture, marketing, and sale of light emitting diode (LED) replacement light bulbs; and LED-based signage, channel letter, and contour lighting products in the United States, Canada, and internationally. The company offers white light LED replacement lamps, and LED signage and lighting strips for use in commercial, hospitality, institutional, retail, and sign markets. It also provides LED signage and lighting strips for non-signage applications, such as vending machines, illuminated display tables, and architectural applications. The company sells its products under the Array Lighting and Lumificient brand names. Nexxus Lighting, Inc. markets and distributes its products through a network of independent sales representatives and distributors, as well as through energy savings companies and national accounts. The company was formerly known as Super Vision International, Inc. and changed its name to Nexxus Lighting, Inc. in April 2007. Nexxus Lighting, Inc. was founded in 1991 and is headquartered in Charlotte, North Carolina.

NEXS News:

September 12 – Nexxus Lighting Announces Additional Investment in Company * Aston Capital, LLC to Invest $6 Million * Technology Industry Pioneer Robert V. LaPenta to Join Nexxus as Chairman of the Board Nexxus Lighting, Inc. (NASDAQ: NEXS) announced that an affiliate of Aston Capital, LLC (the “Investor”) has agreed to invest $6 million in the Company through the purchase of convertible preferred stock to provide strategic, operational and financial expertise with the goal of enabling the Company`s strategic growth and expansion.

Aston Capital, LLC is led by Robert V. LaPenta, a renowned growth investor and leader in the high technology arena. Mr. LaPenta and Aston`s investment philosophy combines sound fundamental operating principles with the ability to identify macroeconomic trends and provide strategic and operational support to management teams to accelerate global growth and build market leaders and shareholder value over the course of the partnership. Aston believes significant value can be built in a partnership with Nexxus by acquiring complimentary assets, and through operational and financial improvements, product line enhancement and expansion of global reach and brand awareness. Aston believes that the LED lighting market is a large and growing nascent market with diverse end users with avenues to create value.

Aston`s goal is to build a dynamic market leader who will be able to address the significant global demand for this critical technology.

“We view the market for LED lighting to be in the early phase of adoption and we see Nexxus Lighting, with their product lines and intellectual property, as a platform on which to build and grow in the market,” stated Robert LaPenta, Chairman and CEO of Aston Capital. “Over the next several years, we believe that LED replacement lamps, luminaires and lighting systems are going to become the new standard in energy efficient lighting applications and we are excited to help Nexxus market and sell their products, build its brand, reach new customers and continue its leadership in innovation to take advantage of these opportunities.” Mike Bauer, President and CEO of Nexxus Lighting, Inc. stated “The last several quarters have been very challenging and the need to find a strong partner became a requirement for the Company. Mr. LaPenta and Aston Capital provide the resources and expertise to help us take advantage of the growing market for LED lighting. They provide Nexxus Lighting with not only financial backing, but also strategic, operational and financial management skills that can help the Company more effectively compete as we work to build the Company into a market leader.” Initially, the Investor will have the right to appoint four members to the Company`s Board of Directors, with the size of the Board not to exceed seven members. In connection with the closing of the investment, all of the current members of the Company`s Board of Directors will resign.

Convertible Preferred Stock On September 12, 2012, Nexxus entered into an investment agreement with the Investor for the purchase of 600,000 shares of newly-created Series B convertible preferred stock at a purchase price of $10 per share. The preferred stock will be convertible into shares of the Company`s common stock at a conversion price equal to $0.13 per share (subject to certain anti-dilution adjustments). The conversion price was the closing price of the Company`s common stock on August 2, 2012, the date the Company and the Investor entered into the letter of intent with respect to the investment.

The proceeds from the investment will be used to extinguish approximately $2.5 million of existing short term debt, to fund a settlement payment in connection with the anticipated settlement of the Philips lawsuit described below, to pay the fees and expenses in connection with the transaction and for working capital purposes, including the planned growth of its Array Lighting LED replacement lamp and Lumificient sign lighting businesses.

After giving effect to the conversion of the preferred stock and the other transactions contemplated by the investment agreement, it is expected that the Investor would own 46,153,846 shares, or approximately 73%, of the Company`s outstanding common stock. The preferred stock will represent approximately 73% of the outstanding voting stock of the Company on an as-converted basis and will result in a change in control of the Company.

The Investor will be entitled to vote the preferred stock on an as-converted basis with the Company`s common stock.

Settlement of Patent Infringement Claim by Philips A portion of the proceeds from the transaction will be used in connection with the anticipated settlement of a lawsuit brought against the Company by Koninklijke Philips Electronics N.V. and Philips Solid-State Lighting Solutions, Inc. (collectively, “Philips”) on March 26, 2012, alleging that the Company`s Array and certain other products infringe certain of Philips` patents for LED lighting. The Company is negotiating a settlement with Philips and, as a result of the transaction, the Company will have the resources to fund the settlement payment. In connection with the contemplated settlement, the Company would receive a license to use certain Philip`s patents for LED Lighting and will pay Philips a royalty with respect to the certain Company products. Settlement of the Philips lawsuit is a condition to the closing of the investment.

Extinguishment of Existing Indebtedness In addition, in connection with closing the investment transaction, approximately $2.5 million in indebtedness represented by existing promissory notes of the Company that mature in June 2013 will be extinguished. The holders of the promissory notes have agreed, subject to closing of the investment transaction, to exchange the promissory notes for a total of $880,000 in cash (which will be funded at closing from the proceeds of the transaction) and 1,000,000 newly-issued shares of the Company`s common stock.

NASDAQ Grants Financial Viability Exception The rules of The NASDAQ Stock Market (“NASDAQ”) would normally require that Nexxus` stockholders approve the investment prior to closing the investment agreement. However, NASDAQ has granted Nexxus an exception from this stockholder voting requirement under Listing Rule 5635(f), which provides that an exception may be granted when (i) the delay in securing stockholder approval would seriously jeopardize the financial viability of the enterprise and (ii) reliance on such exception has been expressly approved by the audit committee of the board of directors comprised solely of independent, disinterested directors. NASDAQ also has granted Nexxus an exception from the voting rights requirements of Listing Rule 5640 and IM-5640 with respect to the transaction. A fairness opinion with respect to the Investor`s investment in the Company has been obtained from PCE Valuations, LLC.

Expected Closing The transaction is expected to close on or about September 24, 2012. The closing is subject to the satisfaction of certain conditions. While the Company anticipates these conditions will be satisfied, uncertainty with respect to the timing of satisfying certain of the conditions may impact the closing date.

As a condition to reliance on the NASDAQ financial viability exception, the Company is mailing a letter to all stockholders not later than ten days before the anticipated closing date to alert them that the Company will not seek, and will not be required to seek, the stockholder approval that would otherwise be required under applicable NASDAQ rules. In addition, the Company is filing a Current Report on Form 8-K with the Securities and Exchange Commission.

BIOFUEL ENERGY CORPORATION (NASDAQ: BIOF) “Up 46.49% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N41&L87&F=T BioFuel Energy Corp. engages in the production of ethanol in the United States. It has two ethanol plants that produce 115 million gallons per year, which are located in Wood River, Nebraska and Fairmont, Minnesota.

The company was founded in 2006 and is headquartered in Denver, Colorado.

BIOF News:

August 17 – Five Star Equities Provides Stock Research on Archer Daniels Midland and BioFuel Energy Skyrocketing corn prices and lower gasoline demand in the U.S. has seen profits of ethanol producers drop drastically. Producers have begun to idle plants and/or slow production as a result. “Even the most profitable plants out there are barely breaking even in the current environment,” said Matthew Farwell, a New York-based analyst for Imperial Capital LLC. Five Star Equities examines the outlook for companies in the Ethanol Industry and provides equity research on Archer Daniels Midland Company (NYSE: ADM) and BioFuel Energy Corp. (Nasdaq: BIOF).

Access to the full company reports can be found at:

www.FiveStarEquities.com/ADM www.FiveStarEquities.com/BIOF Ethanol producers have battled record high corn prices, and tight domestic supply. The drought in the Farm Belt has drove corn-futures to an all-time high in July. Prices have relaxed a bit since then but have still surged over 40 percent since early June. It is estimated that approximately 40 percent of the nation`s corn output is consumed by the ethanol sector.

Major producer Archer Daniels Midland recently stated that their ethanol margins had crumbled to a loss of over 20 cents per gallon.

ADM delivers clean-burning ethanol to refiners through an expansive network of trucks, railcars, barges and terminals. The company makes ethanol from corn through an efficient process that also produces large amounts of animal feed. Bioproducts results for the quarter ended June 30, 2012 decreased $172 million to a loss of $61 million.

Biofuel Energy was founded in 2005 with initial production from two plants commencing in 2008. With both plants active, BioFuel Energy expects to produce 230 million gallons of fuel grade ethanol and approximately 720,000 tons of distiller grains annually.

MASS HYSTERIA ENTERTAINMENT COMPANY (OTC: MHYS) “Up 16.67% in morning trading” Detailed Quote: www.otcpicks.com/quotes/MHYS.php Mass Hysteria Entertainment, Inc. is a multi-media entertainment company created to produce films with an interactive component. The Company most recently completed production in Louisiana on CARJACKED starring Maria Bello and Stephen Dorff. Anchor Bay acquired domestic and English speaking territories and CMG is selling the picture internationally. Mass Hysteria also recently acquired the rights to the romantic comedy SLEEPING TOGETHER written by Steve Smith and Phill Traill and to be directed by Traill.

MHYS News:

August 15 – Mass Hysteria Entertainment Company Signs Memorandums of Understanding to Acquire Real Estate and Air Cargo Businesses Mass Hysteria Entertainment Company, Inc. (OTC: MHYS) announced that it has entered into a non-binding Memorandum of Understanding to acquire a real estate investment/development group which owns properties consisting of a 16 unit rental apartment building with adjacent land with planned use for a second apartment building and 12.4 acres of land for development located adjacent to a key highway intersection both located in Southern California.

In addition, the portfolio includes a beachfront hotel and casino complex called Morgan`s Cove Hotel & Casino and 0.83 acres of land currently planned for the building of a 74 unit condo project called the Palacio, both located in Jaco Beach, Costa Rica.

In addition, MHYS has entered into a non-binding Memorandum of Understanding to acquire an international air cargo business currently operating in Pan-Asia, with plans to acquire aircraft and routes in North America and European regions.

The acquisition of both businesses will be made pursuant to the issuance of MHYS securities for all of the stock of such businesses and, upon closing, these businesses will be wholly-owned subsidiaries of MHYS. The acquisition of both businesses is subject to, among other things, completion of due diligence; completion of financial audits of both businesses; conclusion of definitive agreements; and procurement of any governmental approvals.

Definitive documentation is expected within 90 days. The acquired companies are expected to bring substantial assets in both real estate and aircraft, as well as revenues and operating cash flow.

MHYS will continue to operate its movie business through a wholly-owned subsidiary to be formed concurrently with closing of the acquisitions.

Daniel Grodnik, CEO stated, “Our intent with these acquisitions is to provide diversity to Mass Hysteria`s operating base, as well as enhancing shareholder value. While we will continue on producing and developing opportunities in the motion picture and TV business, we recognize that these efforts will still take some time to show operating results. We expect that the acquisition of these two revenue producing and cash flowing businesses will provide working capital for our company. Each company acquired will be managed as a separate operating wholly-owned subsidiary under the overall supervision and management control of MHYS. We are also thrilled to bring aboard the top management of each company, who will ensure business continuity and leadership as heads of each subsidiary.” ONTECO CORPORATION (OTC: ONTC) “Up 83.33% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N41&L27&F=T Onteco Corporation was founded to develop innovative, practical and cost-effective solutions to some of the most significant environmental challenges facing us today. Additionally, these solutions must show promise of generating significant, ongoing profits for the company. The company determined that one industry that meets these criteria is the Energy Saving Lighting Industry, and as a result acquired NexPhase Lighting, Inc., in February 2011.

ONTC News:

September 13 – Onteco Corporation, ONTC, Enters Into Letter of Intent with Cyber Centers International Corporation Onteco Corporation (OTC: ONTC) (the “Company”, or “Onteco”) announced that it had entered into a Letter of Intent to acquire all of the issued and outstanding shares of Cyber Centers International Corporation, a privately-held Florida corporation, (“CCI”), in exchange for the issuance of a number of shares of common stock of the Company. CCI is in the business of interactive money games.

In accordance with the terms of the Letter of Intent, the Company and CCI will enter into a definitive agreement subject to the successful completion of due diligence and negotiation of the terms of a definitive agreement and related other agreements in a form acceptable to each. At this date, the structure of the transaction between the two companies remains in negotiation, and is expected to be completed within thirty days. In the event a definitive agreement has not been executed by the Company and CCI by September 28, 2012, the Letter of Intent may be terminated.

“We are very excited about this business acquisition by Onteco of CCI,” said Onteco President, Jorge Schcolnik. “We have been working toward this goal for some time. The CCI team is comprised of a highly innovative group of talented gaming developers, and business professionals.” Schcolnik concluded, “For our shareholders, we are extremely confident that CCI will generate a growing revenue stream within a relatively short period of time.” About Cyber Centers International Corporation Cyber Centers International Corporation through its development of an innovative technology for interactive gaming is capitalizing on the growing trend in interactive gaming combined with social marketing. CCI`s vision is to become the benchmark in social money games.

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N41&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N41&L=8&F=T.

Disclosure: OTCPicks.com is not currently being compensated by any of the companies covered in this release.

Related posts:

1. OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, September 13th
2. OTCPicks.com Stocks to Watch for Friday, September 14th
3. OTCPicks.com Stocks to Watch for Wednesday, March 9th
4. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, June 8th
5. OTCPicks.com Stocks to Watch for Thursday, September 1st